| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |